Pharmaceutical Industry in
Pfäffikon SZ

adastra AG

Since 2004 · 1–10 empl.

adastra AG is a floorball club with men’s and youth teams. The club runs competitive and development programs, supports junior players, and provides services for members, volunteers, and sponsors.

MediCrops AG

Since 2019 · 51–100 empl.

The core activity of MediCrops AG is the development and provision of medical cannabis products and therapies. The company focuses on researching and developing innovative products that meet the needs of patients, and aims to revolutionize patient care by optimizing cannabis therapies.

Salus Schweiz AG

Since 2020 · 11–20 empl.

The core activity of Salus Schweiz AG is the development, manufacture and distribution of health products, in particular tonics, teas, elixirs, tablets and other plant-based products.

DiNAQOR AG

Since 2024 · 21–50 empl.

DiNAQOR AG is a biotechnology company builder that develops platform technologies and launches focused companies in tissue science, precision medicine and genetic therapies. Its portfolio includes entities such as DiNATEQ, DiNAMIQS, DiNABiOS and DAiNA; the group provides access to GMP‑compliant viral vector manufacturing and advances precision gene‑therapy programs for cardiomyopathies, heart failure and polycystic kidney disease.

Saiba X AG

Since 2024 · 1–10 empl.

Saiba X AG develops vaccines and virus-like particle technologies for use against chronic and infectious diseases. The company also provides consulting, licensing and development services for vaccine projects.

EuroPharma GmbH

Since 2001 · 1–10 empl.

Sedapharm AG

Since 2004 · 1–10 empl.

HealVax GmbH

Since 2011 · 1–10 empl.

discoveric bio alpha ag

Since 2019 · 1–10 empl.

Besto AG

Since 2020 · 1–10 empl.

Royal Swiss Hemp AG

Since 2021 · 1–10 empl.

AVEXIA HEALTH AG

Since 2021 · 1–10 empl.